Related Experiment Video
Updated: Nov 21, 2025

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
CTCF and EGR1 suppress breast cancer cell migration through transcriptional control of Nm23-H1
Ka Ming Wong1, Jiaxing Song1, Yung H Wong2,3
1Division of Life Science and the Biotechnology Research Institute, Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong.
Abstract:
Tumor metastasis remains an obstacle in cancer treatment and is responsible for most cancer-related deaths. Nm23-H1 is one of the first metastasis suppressor proteins discovered with the ability to inhibit metastasis of many cancers including breast, colon, and liver cancer. Although loss of Nm23-H1 is observed in aggressive cancers and correlated with metastatic potential, little is known regarding the mechanisms that regulate its cellular level. Here, we examined the mechanisms that control Nm23-H1 expression in breast cancer cells. Initial studies in aggressive MDA-MB-231 cells (expressing low Nm23-H1) and less invasive MCF-7 cells (expressing high Nm23-H1) revealed that mRNA levels correlated with protein expression, suggesting that transcriptional mechanisms may control Nm23-H1 expression. Truncational analysis of the Nm23-H1 promoter revealed a proximal and minimal promoter that harbor putative binding sites for transcription factors including CTCF and EGR1. CTCF and EGR1 induced Nm23-H1 expression and reduced cell migration of MDA-MB-231 cells. Moreover, CTCF and EGR1 were recruited to the Nm23-H1 promoter in MCF-7 cells and their expression correlated with Nm23-H1 levels. This study indicates that loss of Nm23-H1 in aggressive breast cancer is apparently caused by downregulation of CTCF and EGR1, which potentially drive Nm23-H1 expression to promote a less invasive phenotype.
Insights
Tumor metastasis, a major cancer challenge, is linked to Nm23-H1 protein levels. This study reveals that transcription factors CTCF and EGR1 regulate Nm23-H1 expression in breast cancer cells, impacting metastasis.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Tumor metastasis is a primary cause of cancer mortality.
- Nm23-H1 is a known metastasis suppressor protein, but its regulatory mechanisms are unclear.
- Loss of Nm23-H1 correlates with increased metastatic potential in aggressive cancers.
Purpose of the Study:
- To investigate the mechanisms controlling Nm23-H1 expression in breast cancer cells.
- To identify transcription factors involved in Nm23-H1 regulation.
- To understand the role of Nm23-H1 regulation in breast cancer cell invasiveness.
Main Methods:
- Comparative analysis of Nm23-H1 expression in MDA-MB-231 (low Nm23-H1) and MCF-7 (high Nm23-H1) breast cancer cells.
- Promoter truncational analysis to identify regulatory regions.
- Investigation of transcription factor binding (CTCF, EGR1) and their effect on Nm23-H1 expression and cell migration.
Main Results:
- Nm23-H1 mRNA and protein levels correlated in breast cancer cell lines, suggesting transcriptional control.
- A proximal promoter region with binding sites for CTCF and EGR1 was identified.
- CTCF and EGR1 induced Nm23-H1 expression and reduced cell migration in MDA-MB-231 cells.
- CTCF and EGR1 were recruited to the Nm23-H1 promoter in MCF-7 cells, correlating with Nm23-H1 levels.
Conclusions:
- Downregulation of CTCF and EGR1 likely contributes to the loss of Nm23-H1 in aggressive breast cancer.
- CTCF and EGR1 play a crucial role in driving Nm23-H1 expression.
- Restoring CTCF and EGR1 expression may promote a less invasive phenotype in breast cancer.
More Related Videos
Related Concept Videos
Mitogens and the Cell Cycle
Master Transcription Regulators
Abnormal Proliferation
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
TGF - β Signaling Pathway
MicroRNAs

